Research Reports

Healthcare

icon
Home » Reports » Radiotherapy Positioning Devices Market
Market Research Report

Radiotherapy Positioning Devices Market By Material (Tape/ Velcro, Polyurethane foam casts, Thermoplastics, Others); By Product Type (Head, Neck and Brain immobilization Device, Thorax and Breast Immobilization Device, Pelvic Immobilization Devices, Others); By End-User (Hospitals, Cancer Research Institutes, Ambulatory surgical centers, Others) - Global Demand Analysis & Opportunity Outlook 2027

Published On : 04:10 AM, 18th July, 2018 REP-ID-880 Category: Healthcare

Global Radiotherapy Positioning Devices Market Overview

Radiotherapy is one of the treatment methods for treating cancer. High energy x-ray or gamma-ray is used to kill the cancer cell. This treatment is given either once or a few times for each patient. Thus, radiotherapy treatment must be delivered accurately. To ensure treatment is given accurately, some accessory devices are needed following the parts of body that will be getting treatment. These accessory devices are used to determine the patient’s position during treatment, to prevent any movement and to make sure patient is comfortable using it. Each patient will use a definite set of accessory which differs according to the type of cancer and area of treatment. This accessory must be durable and can be used repeatedly by the patient until treatment completes. For some patient, customized accessory set is made especially for them. These accessory devices are known as positioning or immobilization devices used in radiotherapy.

Market Size & Forecast

Radiotherapy Positioning Devices Market is anticipated to record a significant CAGR over the forecast period. Many multi-national companies are concentrating towards new product advances in radiotherapy positioning devices to improve their product portfolio which is anticipated to support the global market growth. It is projected by World Health Organization, that by 2030, about 23.6 million new cases of cancer will exist across the world. Governmental guidelines from National Comprehensive Cancer Network (NCCN) and American Society of Clinical Oncology (ASCO) are delivering help to healthcare professionals in the treatment and management of cancer patients. The U.S. Government in April 2016 allocated USD 5.2 Billion for the National Cancer Institute (NCI), for cancer research and training.

On the basis of regional platform, global Radiotherapy Positioning Devices market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North-America holds the largest share in terms of revenue for radiotherapy positioning devices owing to the region’s innate nature of adopting technologies in their primitive stage. Moreover, greater focus on early diagnosis, screening, monitoring and clinical development associated with radiotherapy treatment by market players have affected the radiotherapy positioning devices market positively.

In Asia Pacific region significant economic development has led to an increase in healthcare availability, increase in number of multi-specialty clinics and hospitals, and rise in popularity of radiotherapy positioning devices among oncologists. Further preference of minimally invasive techniques and penetration of global players in Asia is expected to fuel demand for radiotherapy positioning devices market in the region.

Radiotherapy Positioning Devices Market Size

Market Segmentation

Our-in depth analysis of the global radiotherapy positioning devices market includes the following segments:

By Material

  • Tape/ Velcro
  • Polyurethane foam casts
  • Thermoplastics
  • Others

By Product Type

  • Head, Neck and Brain immobilization Device
  • Thorax and Breast Immobilization Device
  • Pelvic Immobilization Devices
  • Others

By End-User

  • Hospitals
  • Cancer Research Institutes
  • Ambulatory surgical centers
  • Others

 By Region

Global radiotherapy positioning devices market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of Asia) Market size, Y-O-Y growth & Opportunity Analysis.
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Global Radiotherapy Positioning Devices  Market Share

Growth Drivers & Challenges

Rising flexible financing by government and federal agencies for cancer research, increasing prevalence of cancer among growing population, availability of new cancer treatment, upsurge in healthcare coverage, and other device accessory for the patients during the treatment process are some of the aspects supporting the radiotherapy positioning devices market. Growing aspiration of manufacturers of radiotherapy positioning devices to advance the products for the healthcare specialists and patients across the world to deliver high quality, innovative and unique patient-centric radiotherapy positioning devices is expected to help the market grow. These devices are precise and offer maximum repositioning precision and patient steadiness by lowering both voluntary and involuntary patient movement. Radiotherapy positioning device’s accurate & comfortable design cuts the risk injuries among healthcare professionals, escalating workflow efficiencies and accurate delivery of prescribed radiation doses which will behave as some of the dynamics enhancing the radiotherapy positioning devices market. Significant economic development has led to an increase in healthcare availability in developing regions which is further expected to propel the radiotherapy positioning devices market growth.

However, insurance coverage and reimbursement issues, associated to healthcare in many countries combined with radiation risk to healthcare professionals and patients undergoing radiation therapy are anticipated to act as certain aspects that can obstruct the radiotherapy positioning devices market growth.

Key Players

  • CIVCO Radiotherapy
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Elekta AB
  • Bionix Radiation Therapy
  • ORFIT INDUSTRIES NV
  • Qfix
  • VERTEC LTD
  • Klarity Medical Products
  • Varian Medical Systems, Inc.
  • IZI Medical Products
  • Unger-Medizintechnik GmbH & Co.KG
  • Lansdowne Chemicals

Scope & Context

Overview of the Parent Market

Analyst View

Segmentation

The Global Radiotherapy Positioning Devices Market is segmented as follows:

  • By Material Type Market Size & Y-O-Y Growth Analysis
  • By Product Type Market Size & Y-O-Y Growth Analysis 
  • By End-User Industries Market Size & Y-O-Y Growth Analysis
  • By Region Market Size & Y-O-Y Growth Analysis

Market Dynamics

Supply & Demand Risk

Competitive Landscape

Porter’s Five Force Model

Geographical Economic Activity

Key Players (respective SWOT Analysis) and their Strategies and Product Portfolio

Recent Trends and Developments

Industry Growth Drivers and Challenges

Key Information for Players to establish themselves in current dynamic environment

key Answers

SELECT LICENSE TYPE

KEY BENEFITS

  • DIRECT ANALYST ASSISTANCE

    Direct access to analyst to help you understand the market in a better way to handle your critical question

  • CUSTOMIZE AS PER YOUR NEED

    Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved

  • DISCOUNT ON CUSTOMISATION

    Get 10% free customization

  • QUALITY ASSURED

    Great focus on accuracy and quality of the research

Connect With Us

Call us

(U.S.) - +1 646 586 9123
(Canada) - +1 437 889 3230
(U.K.) - +44 203 608 5919
(India) - + 91 120 660 5495
Email: info@researchnester.com

Ask The Analyst

Delivery Center

Ansal Corporate Park, Plot no 7A/1,
Tower A1,
Sector 142 Noida., 201301 India
info@researchnester.com

US Office

77 Water Street 8th Floor,
New York, New York, 10005
Phone : +1 646 586 9123
info@researchnester.com

Canada (Toronto)

Phone : +1 437 889 3230
info@researchnester.com

UK Office (London)

Phone : +44 203 608 5919
info@researchnester.com

Copyright © 2018 Research Nester. All rights reserved

Top